We are live on
!
Find out more
C
CEDRUS Portfolio holdings
AUM
$270M
1-Year Est. Return
25.5%
This Fund
S&P 500
This Quarter
Est. Return
+6.96%
1 Year Est. Return
+25.5%
3 Year Est. Return
+19.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$183M
AUM Growth
+$21.6M
(+13%)
Cap. Flow
+$10.9M
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
41.31%
Holding
160
New
10
Increased
64
Reduced
69
Closed
10
Avg Time Held Equity + Options
6.2
quarters
Top 10 Avg Time Held Equity + Options
6
quarters
Top 20 Avg Time Held Equity + Options
6.6
quarters
Avg Time Held Equity only
6.2
quarters
Top 10 Avg Time Held Equity only
6
quarters
Top 20 Avg Time Held Equity only
6.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Trust Smith Opportunistic Fixed Income ETF
FIXD
|
+$2.39M |
| 2 |
Pacer US Small Cap Cash Cows 100 ETF
CALF
|
+$1.54M |
| 3 |
FT Vest Rising Dividend Achievers Target Income ETF
RDVI
|
+$1.36M |
| 4 |
FT Vest US Equity Moderate Buffer ETF February
GFEB
|
+$847K |
| 5 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$842K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab U.S Small- Cap ETF
SCHA
|
+$1.06M |
| 2 |
First Trust Low Duration Strategic Focus ETF
LDSF
|
+$617K |
| 3 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$508K |
| 4 |
Vanguard Morningstar Mid-Cap Value ETF
VOE
|
+$419K |
| 5 |
Gilead Sciences
GILD
|
+$377K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 76.04% |
| 2 | Technology | 4.93% |
| 3 | Financials | 3.92% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Communication Services | 2.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
US Bancorp
USB
$89.5B
| $353K | 0.19% |
7,892
-1,583
| -17% | -$66.8K |
2023 Q3
2 quarters
|
|
102
Entergy
ETR
$48.7B
| $349K | 0.19% |
6,598
-1,458
| -18% | -$73.9K |
2022 Q2
7 quarters
|
|
103
Cincinnati Financial
CINF
$25.1B
| $345K | 0.19% |
2,782
-558
| -17% | -$63K |
2021 Q4
9 quarters
|
|
104
Pfizer
PFE
$155B
| $343K | 0.19% |
12,377
+5,158
| +71% | +$143K |
2021 Q4
9 quarters
|
|
105
Quanta Services
PWR
$107B
| $341K | 0.19% |
1,312
-148
| -10% | -$32.7K |
2023 Q1
4 quarters
|
|
|
NVO
106
Novo Nordisk
NVO
$163B
| $341K | 0.19% |
+2,652
| New | +$316K |
2024 Q1
0 quarters
|
|
107
First Trust Exchange-Traded Fund IV First Trust High Income Strategic Focus ETF
HISF
$95.3M
| $340K | 0.19% |
7,689
+550
| +8% | +$24.4K |
2021 Q4
9 quarters
|
|
108
Merck
MRK
$345B
| $337K | 0.18% |
2,554
-824
| -24% | -$102K |
2021 Q4
9 quarters
|
|
109
T-Mobile US
TMUS
$176B
| $336K | 0.18% |
2,060
-227
| -10% | -$36.9K |
2021 Q4
9 quarters
|
|
110
NXP Semiconductors
NXPI
$61.4B
| $335K | 0.18% |
1,352
-82
| -6% | -$18.9K |
2023 Q4
1 quarter
|
|
111
Schwab US Large- Cap ETF
SCHX
$75.4B
| $332K | 0.18% |
16,032
-4,275
| -21% | -$84.2K |
2023 Q4
1 quarter
|
|
112
EOG Resources
EOG
$75.8B
| $328K | 0.18% |
2,568
-205
| -7% | -$23.9K |
2022 Q2
7 quarters
|
|
113
Hartford Financial Services
HIG
$34.4B
| $323K | 0.18% |
3,138
-1,647
| -34% | -$151K |
2021 Q4
9 quarters
|
|
114
VanEck Morningstar Wide Moat ETF
MOAT
$11.5B
| $313K | 0.17% |
3,483
+125
| +4% | +$10.7K |
2023 Q2
3 quarters
|
|
115
First Trust Exchange-Traded Fund VI First Trust BuyWrite Income ETF
FTHI
$2.57B
| $309K | 0.17% |
+13,750
| New | +$302K |
2024 Q1
0 quarters
|
|
116
iShares S&P 500 Growth ETF
IVW
$80.6B
| $307K | 0.17% |
3,636
-454
| -11% | -$36.5K |
2021 Q4
9 quarters
|
|
117
LyondellBasell Industries
LYB
$19.1B
| $300K | 0.16% |
2,931
-609
| -17% | -$59.3K |
2022 Q4
5 quarters
|
|
118
Thermo Fisher Scientific
TMO
$245B
| $299K | 0.16% |
515
-29
| -5% | -$16.3K |
2021 Q4
9 quarters
|
|
119
Inspire 100 ETF
BIBL
$519M
| $291K | 0.16% |
7,482
| – | – |
2022 Q3
6 quarters
|
|
120
Dominion Energy
D
$54B
| $291K | 0.16% |
5,918
-1,128
| -16% | -$52.7K |
2022 Q3
6 quarters
|
|
121
Vertex Pharmaceuticals
VRTX
$126B
| $291K | 0.16% |
696
-95
| -12% | -$40.2K |
2023 Q4
1 quarter
|
|
122
Roper Technologies
ROP
$35.7B
| $284K | 0.16% |
507
-18
| -3% | -$9.82K |
2021 Q4
9 quarters
|
|
123
Sempra
SRE
$51.6B
| $284K | 0.16% |
3,952
-711
| -15% | -$51K |
2022 Q2
7 quarters
|
|
124
Citigroup
C
$217B
| $281K | 0.15% |
4,444
+189
| +4% | +$10.5K |
2023 Q4
1 quarter
|
|
125
Vanguard Morningstar Small-Cap Value ETF
VBR
$35.7B
| $281K | 0.15% |
1,464
-34
| -2% | -$6.13K |
2022 Q2
7 quarters
|
|
Similar funds
MFG
T
BWM
IF
BFA
CHA
FSI
S
CEDRUS's Q1 2024 Portfolio in Review
As of Q1 2024, CEDRUS held 160 positions worth $183M, up 13% from $161M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
CEDRUS deployed $10.9M of net new capital in Q1 2024, opening 10 new positions and adding to 64 existing holdings. Its largest new stake was FT Vest US Equity Moderate Buffer ETF February: 25,170 shares worth $867K.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, up from 74% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Schwab U.S Small- Cap ETF, an estimated $1.06M trimmed.
- CEDRUS's largest Q1 2024 buy was FT Vest US Equity Moderate Buffer ETF February: 25,170 shares worth $867K.
- CEDRUS added most to First Trust Smith Opportunistic Fixed Income ETF in Q1 2024, an estimated $2.39M increase.
- CEDRUS's biggest Q1 2024 reduction was Schwab U.S Small- Cap ETF, cutting an estimated $1.06M.
- CEDRUS fully exited iShares Ultra Short Duration Bond Active ETF in Q1 2024, selling an estimated $508K.
- CEDRUS's ten largest holdings make up 41% of its $183M portfolio in Q1 2024.
- CEDRUS opened 10 new positions and closed 10 in Q1 2024.
- CEDRUS's portfolio value rose 13% quarter-over-quarter to $183M.
Based on CEDRUS's 13F filing for Q1 2024, filed 15 Apr 2024.